New study to see if emicizumab protects joints in kids with hemophilia
NCT ID NCT07190118
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study looks at how emicizumab, a medicine given under the skin, affects the muscles and joints of children with hemophilia A. Researchers will measure pain, joint health, balance, and movement in 20 children under 18. The goal is to understand if this treatment helps prevent long-term joint damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hasan Kalyoncu University
Gaziantep, Gaziantep, (505) 090-5846, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.